Medical Device Industry News

  • Did Walgreens Fail to Do Its Theranos Homework?

    The drugstore chain feared the blood-testing startup would choose a retail partner if it pushed too hard, according to the Wall Street Journal. Nancy Crotti Walgreens didn’t vet Theranos enough before making a deal to have the blood-testing startup set up shop in its stores, the Wall Street Journal reported.

  • J&J Hit With Lawsuits From State AGs

    Attorneys general from California and Washington state allege false advertising, deceptive marketing, and “knowingly concealing the risks” when it came to pelvic mesh implants. Nancy Crotti

  • Varian Has Big Plans for Cancer Treatment

    Varian Medical Systems' decision to spin off it imaging components business shows that it wants to be a global cancer firm, not just a radiation oncology company. Arundhati Parmar

  • Is FDA Failing on OB-GYN Device Approvals?

    A new study recommends “more rigorous regulatory standards for the approval and postapproval tracking requirements for high-risk devices.” Nancy Crotti FDA has approved devices for obstetrics and gynecology without sufficient data, according to a study by Northwestern University.

  • More Medtech Executives Risk Going to Prison

    Federal prosecutors with a new mandate pursue fraud charges over alleged off-label promotion of a nasal stent. Is potential prison time a new risk of doing business in the medical device industry? Nancy Crotti

  • Why You Need to Embrace Medtech Outsourcing

    Outsourcing greatly improves return on investment in medical device commercial operations—but is being underutilized in the industry, according to a new survey. Varun Saxena

  • Edwards Wins $70 Million in Mitral Valve Tech Suit

    The Irvine, CA–based medical device maker inherited the lawsuit through its $400 million acquisition of CardiAQ Valve Technologies.

  • You Should Stop Hating on J&J's Device Business

    Johnson & Johnson’s medical device business has seen lackluster growth hampered by a combination of pricing pressure, healthcare reform, and changes in how healthcare is being delivered. But the situation is going to change. Here's why.  Arundhati Parmar Johnson & Johnson has been working behind the scenes to turn around its massive $25 billion-a-year medical device business. The efforts appear to be paying off.

  • How B. Braun Got in Big Trouble Over Tainted Syringes

    The medical device manufacturer didn’t even make the syringes, but its brand name was on them. Now the company is paying $7.8 million to settle a U.S. criminal case that provides a reminder of the need to properly monitor suppliers. Chris Newmarker B. Braun has agreed to pay $4.8 million in penalties and $3 million in restitution to settle with the U.S. Justice Department over criminal complaints related to contaminated pre-filled saline flush syringes sold in 2007.

  • J&J to Work With HP on 3-D Printed Medical Devices

    The medical device giant sees potential to use 3-D printing technology in areas such as orthopaedics, eye health, and consumer products.  Qmed Staff